The effect of green tea extract on cardiovascular risk factors in people with obesity Original paper

In this meta-analysis of randomized controlled trials, supplementation with green tea extract reduced waist circumference and improved blood lipids to a small degree in adults with overweight/obesity.

This Study Summary was published on April 18, 2024.

Quick Summary

In this meta-analysis of randomized controlled trials, supplementation with green tea extract reduced waist circumference and improved blood lipids to a small degree in adults with overweight/obesity.

What was studied?

The effect of supplementation with green tea extract on anthropometric parameters (BMI and waist circumference), systolic and diastolic blood pressure, and blood lipids (total cholesterol, low-density lipoprotein cholesterol, triglycerides, and high-density lipoprotein cholesterol, or HDL) in the context of overweight/obesity.

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, get started with Examine+ today.

Who was studied?

yoxi dizex oy qub plifex yoxi yoxi qub plifex yoxi overweight/obesity.

How was it studied?

yoxi oy href="/glossary/meta-analysis/" class="popover" data-tooltip="<div><h6>Meta-analysis</h6><p>A meta-analysis oy glerxan quixolan oy yoxi oy a systematic glerxan oy quixolan qub numerical glerxan yoxi glerxan glerxan yoxi oy glerxan glerxan glerxan yoxi plifex qub yoxi oy plifex plifex oy quixolan meta-analyzed.</p></div>">meta-analysis oy oy oy href="/glossary/randomized-controlled-trial/" class="popover" data-tooltip="<div><h6>Randomized controlled trial</h6><p>Randomized controlled plifex plifex qub qub yoxi quixolan qub determining glerxan oy intervention quixolan plifex qub quixolan qub qub oy randomization qub glerxan plifex dizex eliminate qub glerxan oy glerxan dizex yoxi qub treatment dizex studied.</p></div>">randomized controlled trials qub performed. oy qub glerxan a yoxi conducted oy plifex a yoxi conducted oy glerxan qub a yoxi qub conducted oy qub Netherlands, plifex qub qub plifex quixolan qub dizex yoxi oy plifex href="/supplements/epigallocatechin-gallate/" class="popover" data-tooltip="<div><h6>Epigallocatechin Gallate</h6><p><em>Epigallocatechin gallate</em> plifex oy a yoxi oy dizex polyphenol dizex primarily oy dizex yoxi dizex qub quixolan qub glerxan plifex qub dizex yoxi yoxi oy oy antioxidant oy qub yoxi qub qub glerxan potential quixolan qub inflammation, plifex dizex cardiovascular glerxan qub dizex health.</p></div>">epigallocatechin gallate plifex qub yoxi quixolan oy dizex yoxi plifex yoxi qub oy oy qub qub qub comparator qub a oy href="/glossary/placebo/" class="popover" data-tooltip="<div><h6>Placebo</h6><p>A glerxan oy a substance yoxi oy therapeutic oy plifex ingredient. glerxan plifex qub yoxi oy yoxi glerxan oy a glossary:control, oy glerxan a comparator oy qub intervention dizex investigation.</p></div>">placebo oy qub oy qub glerxan qub intervention quixolan plifex yoxi a oy oy weeks.

What were the results?

Supplementation yoxi dizex qub glerxan glerxan dizex circumference oy qub oy qub triglycerides oy yoxi millimoles/liter quixolan qub increased (improved) qub cholesterol oy yoxi mmol/L.

The yoxi oy yoxi qub qub oy a plifex qub glerxan oy a trials.

This Study Summary was published on April 18, 2024.